← Search all jobs

SVP/Global Head, Regulatory Affairs

Cornerstone Search Group

Listing collected from Cornerstone Search Group's career site. NextChapter is independent of Cornerstone Search Group.

Boston, MA · Posted September 30, 2026

Just laid off? Start here: a plan for the first weeks

Want recruiters in Legal to be able to find you?

Roles at this level, like this one at Cornerstone Search Group, are often filled through recruiters.

See every open role at Cornerstone Search Group

More in Massachusetts job market · Pharmaceuticals & Biotech · Legal jobs

More roles at Cornerstone Search Group

Similar jobs

Where Boston, MA ranks

Where Boston, MA placed in our monthly rankings, month by month. Each month stays online at its own address.

Rankings about legal jobs

Legal jobs · Top Legal employers · All rankings

How AI is used in this kind of work

AI use among managers, all other is little observed so far. Measured exposure for managers, all other: 7% (little observed).

Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.

Check how this applies to your own job

Skills this job asks for

Say which you have and which you want to build. We use it to match you to jobs like this one.

About the job

Our client, a novel, rapidly-growing clinical-stage biotechnology company, has retained us to identify a Senior Vice President, Regulatory Affairs to lead its growing global regulatory organization.

This is a highly visible senior leadership role at a pivotal stage of the company’s evolution, with multiple programs advancing through clinical development toward late-stage development and potential registration. The SVP will serve as the company’s senior-most regulatory leader, partnering closely with the executive team, Board and cross-functional leadership while representing the organization with the FDA and other global health authorities.

The position offers the opportunity to shape the regulatory strategy, infrastructure and team required to advance a novel class of medicines from clinical development through potential approval and commercialization.